Pyrotinib Maleate Tablets
Sponsors
West China Hospital, Wuhan University, Tianjin Medical University Cancer Institute and Hospital, Risen (Suzhou) Pharma Tech Co., Ltd.
Conditions
Advanced Solid TumorsBreast CancerCombination ChemotherapyHER2 PositiveHER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
Phase 1
Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer
NCT04152057
Start: 2019-11-30End: 2021-04-30Target: 20Updated: 2019-11-05
A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors
RecruitingNCT06208410
Start: 2024-01-11End: 2027-02-26Target: 306Updated: 2025-07-25